Inventor · disambiguated record
Thomas Schlüter
Also filed as: SCHLÜTER THOMAS
7 granted patents·3 pending applications·65 citations·filing 2007–2025
84Inventor score
Top patents by PatentIndex Score
10 records- 0192US12059449B2Ophthalmic composition for treatment of dry eye diseaseNOVALIQ GMBH·Filed 2022·Granted Aug 13, 2024·5 cites·17 claims
- 0292US11413323B2Ophthalmic composition for treatment of dry eye diseaseNOVALIQ GMBH·Filed 2021·Granted Aug 16, 2022·10 cites·22 claims
- 0389USD978875SVehicle display with graphical user interfaceCLAAS KGAA MBH·Filed 2021·Granted Feb 21, 2023·16 cites·1 claims
- 0485US11896559B2Opthalmic compositions comprising F6H8NOVALIQ GMBH·Filed 2018·Granted Feb 13, 2024·7 cites·20 claims
- 0585USD916730SVehicle display with graphical user interfaceCLAAS KGAA MBH·Filed 2018·Granted Apr 20, 2021·25 cites·1 claims
- 0671US2024374678A1Ophthalmic composition for treatment of dry eye diseaseNOVALIQ GMBH·Filed 2024·Application pending·0 cites
- 0763US2025295607A1Ophthalmic compositions for treatment of ocular surface damage and symptoms of drynessNOVALIQ GMBH·Filed 2025·Application pending·0 cites
- 0857US9815039B2BioreactorSCHLÜTER THOMAS·Filed 2007·Granted Nov 14, 2017·2 cites·18 claims
- 0947US2021346313A1Ophthalmic compositions for treatment of ocular surface damage and symptoms of drynessNOVALIQ GMBH·Filed 2019·Application pending·0 cites
- 1032US8940722B2Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseaseKINZEL OLAF·Filed 2011·Granted Jan 27, 2015·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Schlüter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →